Connexion
M'inscrire

Votre recherche

Filtres

Project précédent
Projet suivant
Nous verifions auprès de chaque centre si des nouvelles informations sont disponibles

CDR0000305866

Esophagectomy in treating patients with high-grade dysplasia of the esophagus or stage i, stage ii, or stage iii esophageal cancer
Source : Importé depuis le centre

Référence clinicaltrials.gov: NCT00063986
esophageal cancer
minimally invasive esophagectomy (MIE)
Source : Importé depuis le centre
Esophageal Cancer
Recrutement fermé
Dernière modification : 2023/06/30
Type de recherche

Interventionnel

Médicament expérimental

Phase 2


Population cible

Condition médicale (spécialité visée)

Choix aire thérapeutique

Esophageal Cancer

Source : Importé depuis le centre

Profil des participants

Sexe(s) des participants

All

Source : Importé depuis le centre

Critères de sélection

Critères d'inclusion

INCLUSION CRITERIA:

DISEASE CHARACTERISTICS:

High grade dysplasia of the esophagus who would undergo esophagectomy OR esophageal cancer at stage T1-T3, N0-N1 who require esophagectomy (patients with M1 disease and/or bulky lymph node involvement were excluded).
Pathological confirmation of a diagnosis of cancer or high-grade dysplasia of the esophagus by biopsy.
Computerized tomography (CT) scan of chest and abdomen within 6 weeks prior to registration
Stomach must be available for conduit
Age of 18 and over
ECOG performance status of 0-2
Creatinine less than 2 mg/dL
Patients with esophageal cancer who would be treated with neoadjuvant chemotherapy and/or radiation were eligible. If patients were registered prior to receiving neoadjuvant chemotherapy they were allowed up to 5 months to complete therapy and any restaging that was necessary before operation was performed.

The patient was considered an appropriate candidate for surgery based on preoperative clinical staging and physiological factors prior to registration as documented in the surgical plan. Pre-operative staging should include:

Endoscopic ultrasound (EUS)
Positron emission tomography (PET) scan and/or laparoscopic staging (Laparoscopic staging could be performed on the day of resection. Additional evaluation was recommended if the PET scan suggested distant metastatic disease.)

EXCLUSION CRITERIA:

Cancer extending into the stomach more than 20%
Prior anti-reflux or gastric operations
Prior right thoracotomy
Prior major neck operation other than the removal of superficial skin lesion

Source : Importé depuis le centre

Thérapie ou Intervention proposée

Cohortes
Nom Condition médicale Traitement État du recrutement
Minimally invasive esophagectomy (MIE) Donnée non disponible Within 4 weeks of registration patients will undergo minimally invasive esophagectomy (MIE). However, there will be up to 5 months allowed between registration and MIE for those patients needing neoadjuvant therapy prior to undergoing MIE.
  • Inconnu
  • Minimally invasive esophagectomy (MIE)
    État du recrutement
    unknown
    Données à jour depuis : 30 juin 2023

    Description de l'étude

    Résumé de l'étude

    RATIONALE: Laparoscopic-assisted surgery and video-assisted thoracoscopy are less invasive types of surgery for esophageal cancer that may have fewer side effects and improve recovery.

    PURPOSE: This phase II trial is studying how well laparoscopic-assisted surgery and video-assisted thoracoscopy work in treating patients who are undergoing esophagectomy for high-grade dysplasia of the esophagus or stage I, stage II, or stage III esophageal cancer.

    Source : Importé depuis le centre

    OBJECTIVES:

    Determine the feasibility of performing minimally invasive esophagectomy (MIE), in terms of 30-day mortality, in patients with high-grade dysplasia of the esophagus or stage I-III esophageal cancer.
    Determine the complications associated with this procedure in these patients.
    Determine the rate at which conversion to open operation is required in patients undergoing this procedure.
    Determine the length of the operation, duration of intensive care unit stay, and length of hospital stay in patients undergoing this procedure.
    Determine feasibility and conversion rate of MIE after neoadjuvant therapy.
    Assess the effectiveness of lymph node dissection by MIE by recording the total number of lymph nodes dissected.
    Assess outcomes at follow-up to three years.

    OUTLINE: This is a multicenter study.

    Patients undergo minimally invasive esophagectomy comprising video-assisted thoracoscopy to mobilize the thoracic esophagus in combination with laparoscopy to complete the esophagectomy and a neck incision to mobilize the cervical esophagus. Mortality at 30 days is assessed.

    Patients are followed every 3 months for 2 years and then every 6 months for 1 year.

    ACTUAL ACCRUAL: A total of 110 patients were accrued for this study.

    Source : Importé depuis le centre

    Sites

    Centres participants

      10 affichés sur 41 centres
    • ADENA REGIONAL MEDICAL CENTER

      Chillicothe

      OHIO, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • ALEGANT HEALTH CANCER CENTER AT BERGAN MERCY MEDICAL CENTER

      Omaha

      NEBRASKA, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • ARTHUR G. JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE AT OHIO STATE UNIVERSITY MEDICAL CENTER

      Columbus

      OHIO, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • BOSTON UNIVERSITY CANCER RESEARCH CENTER

      Boston

      MASSACHUSETTS, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • CCOP - COLUMBUS

      Columbus

      OHIO, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • CCOP - MISSOURI VALLEY CANCER CONSORTIUM

      Omaha

      NEBRASKA, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • CHAO FAMILY COMPREHENSIVE CANCER CENTER AT UNIVERSITY OF CALIFORNIA IRVINE MEDICAL CENTER

      Orange

      CALIFORNIA, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • COMMUNITY HOSPITAL OF SPRINGFIELD AND CLARK COUNTY

      Springfield

      OHIO, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • CREIGHTON UNIVERSITY MEDICAL CENTER

      Omaha

      NEBRASKA, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ
    • CURTIS AND ELIZABETH ANDERSON CANCER INSTITUTE AT MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER

      Savannah

      GEORGIA, UNITED STATES

      Recrutement local
      État du recrutement: FERMÉ

    Dernière modification : 30 juin 2023
    Données à jour depuis : 30 juin
    Origine des données : clinicaltrials.gov
    Référence clinicaltrials.gov: NCT00063986